NFE2L2 and in situ carcinoma: Accumulating evidence indicates that numerous flavonoids have demonstrated therapeutic and preventive properties against CIS nephrotoxicity through modulating ROS, inflammatory responses, and Nrf2/HO-1 signaling [19,20,21].